Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cycloph osphamide;Remisión clínica completa prolongada en pacientes con pénfigo vulgar grave después del tratamiento con ciclos intravenosos de ciclofosfamida

Actas Dermo-Sifiliograficas

Volumn 100, Issue 2, 2009, Pages 113-120

  Espana A ^a   Panizo, C ^a   Fernandez S ^a   Marquina, M ^a   Pretel, M ^a   Aguado, L ^a   Sanchez Ibarrola A ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Autoantibodies; Cyclophosphamide; Desmoglein; Immunosuppressants; Pemphigus vulgaris

Indexed keywords

ALENDRONIC ACID; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 3 ANTIBODY; GRANISETRON; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ONDANSETRON; PREDNISONE; RIFAMPICIN;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; MALE; MUCOSAL DISEASE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PEMPHIGUS VULGARIS; PLASMAPHERESIS; PROPHYLAXIS; PROSPECTIVE STUDY; REMISSION; SKIN DEFECT; SKIN DISEASE; TREATMENT DURATION; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; ADULT; AUTOANTIBODIES; AUTOANTIGENS; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DESMOGLEIN 1; DESMOGLEIN 3; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MALE; METHOTREXATE; MIDDLE AGED; MYCOPHENOLIC ACID; NAUSEA; PEMPHIGUS; REMISSION INDUCTION;

EID: 63849095772     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S1578-2190(09)70026-5     Document Type: Article

References (31)

1. J. Sánchez-Pérez, and A. García-Díez Pénfigo Actas Dermosifiliogr 96 2005 329 356
2. S. Beissert, T. Werfel, U. Frieling, M. Böhm, M. Sticherling, and R. Stadler A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus Arch Dermatol 142 2006 1447 1454
3. J.C. Bystryn Adjuvant therapy of pemphigus Arch Dermatol 120 1984 941 951
4. J.C. Bystryn, and N.M. Steinman The adjuvant therapy of pemphigus Arch Dermatol 132 1996 203 208
5. G.G. Toth, and M.F. Jonkman Therapy of pemphigus Clin Dermatol 19 2001 761 767
6. D.F. Mutasim Management of autoimmune bullous diseases: Pharmacology and therapeutic J Am Acad Dermatol 51 2004 859 877
7. J.S. Pasricha, and U.K. Khan Intermittent high-dose dexamethasone- cyclophosphamide therapy for pemphigus Br J Dermatol 119 1988 73 77
8. A.G. Pandya, and R.D. Sontheimer Treatment of pemphigus vulgaris with pulse intravenous CF Arch Dermatol 128 1992 1626 1630
9. J.S. Pasricha, B.K. Khaitan, R.S. Raman, and M. Chandra Dexamethasone-cyclophosphamide pulse therapy for pemphigus Int J Dermatol 34 1995 875 882
10. R. Bhat, V.K. Sharma, M. Ramam, and A. Kumar Cyclophosphamide pulses with oral prednisolone in the treatment of pemphigus: a pilot study Dermatol Online J 11 2005 4
11. M.E. Fleischli, R.H. Valek, and A.G. Pandya Pulse intravenous cyclophosphamide therapy in pemphigus Arch Dermatol 135 1999 57 61
12. V.P. Werth Pulse intravenous cyclophosphamide for treatment of autoimmune blistering diseases: Is there an advantage over the oral route? Arch Dermatol 133 1997 229 230
13. M.J. Fellner, and A.N. Sapadin Current therapy of pemphigus vulgaris Mt Sinai J Med 68 2001 268 278
14. D.L. Cummins, D. Mimouni, G.J. Anhalt, and C.H. Nousari Oral cyclophosphamide for treatment of pemphigus vulgaris and foliaceus J Am Acad Dermatol 49 2003 276 280
15. L.H. Frasier, S. Kanekal, and J.P. Kehrer Cyclophosphamide toxicity: characterizing and avoiding the problem Drugs 42 1991 781 795
16. V.C. Ho, and D. Zloty Immunosuppressive agents in dermatology Dermatol Clin 11 1993 73 85
17. G.L. Baker, L.E. Kahl, B.C. Zee, B.L. Stolzer, A.K. Agarwal, and T.A. Medsger Jr Malignancy following treatment of rheumatoid arthritis with cyclophosphamide Am J Med 83 1987 1 9
18. C. Talar-Williams, Y.M. Hijazi, M.M. Walther, W.M. Linehan, C.W. Hallahan, and I. Lubensky Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener's granulomatosis Ann Intern Med 124 1996 477 484
19. A.R. Ahmed, and S.M. Hombal Cyclophosphamide (Cytoxan): A review on relevant pharmacology and clinical uses J Am Acad Dermatol 11 1984 1115 1126
20. C.Q. Jia, Z.Q. Chen, H.L. Li, P.G. Cui, and W.Y. Xu Weekly CF pulse therapy combined with corticosteroids in the treatment of pemphigus Zhongguo Yi Xue Ke Xue Yuan Xue Bao 23 2001 173 175
21. A.J. Kanwar, S. Kaur, and G.P. Thami Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus Dermatology 204 2002 228 231
22. H.H. Euler, H. Loffler, and E. Christophers Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris Arch Dermatol 123 1987 1205 1210
23. M.S. Turner, D. Sutton, and D.N. Sauder The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris J Am Acad Dermatol 43 2000 1058 1064
24. P. Citarrella, V. Gebbia, P. Di Marco, M. Tambone Reyes, G. Noto, and M. Arico Cyclophosphamide plus vincristine and prednisone in the treatment of severe pemphigus vulgaris refractory to conventional therapy J Chemother 4 1992 56 58
25. M.V. Hayag, J.A. Cohen, and F.A. Kerdel Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris J Am Acad Dermatol 43 2000 1065 1069
26. C.H. Nousari, R. Brodsky, and G.J. Anhalt Evaluating the role of immunoabaltive high-dose cyclophosphamide therapy in pemhigus vulgaris J Am Acad Dermatol 49 2003 148 150
27. J.S. Pasricha Pulse therapy in pemphigus and other diseases 2nd ed. 2000 Pulse therapy and pemphigus Foundation New Delhi
28. R. TanLim, and J.C. Bystryn Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies J Am Acad Dermatol 22 1990 35 40
29. A. España, M. Fernández-Galar, P. Lloret, A. Sánchez-Ibarrola, and C. Panizo Long-term complete remission of severe pemphigus vulgaris with monoclonal anti-CD20 antibody therapy and immunophenotype correlations J Am Acad Dermatol 50 2004 974 976
30. P. Joly, H. Mouquet, J.C. Roujeau, M. D'Incan, D. Gilbert, and S. Jacquot A single cycle of rituximab for the treatment of severe pemphigus N Engl J Med 357 2007 545 552
31. G. Pitarch, J.L. Sánchez-Carazo, J. Pardo, A. Torrijos, E. Roche, and J.M. Fortea Tratamiento de pénfigo vulgar grave resistente con rituximab Actas Dermosifiliogr 97 2006 48 51